
Marking a New Era in Medical Device Development
The partnership between Medevio and CorTec combines Medevio’s advanced production capabilities with CorTec’s expertise in the development, prototyping and small series production for nerve cuff and paddle electrodes, capable of sensing and stimulation. Together, they will address the neuromodulation market’s growing demand for innovative, high-quality implantable components. Medevio will refer early-phase complex prototype development projects for cuff and paddle electrodes to CorTec, while CorTec will leverage Medevio’s exclusive capabilities to scale production efficiently for high-volume manufacturing of such electrodes.
This unique synergy reinforces both companies’ commitment to providing unparalleled quality, expertise, and customer support in advancing medical innovation.
"We are thrilled to partner with a company as innovative and driven as CorTec," said Toiné Warren, Executive Vice President, Commercial at Heraeus Medevio. "It is an opportunity to leverage each other’s expertise to provide a wider breadth of offerings to meet our customers’ needs in the neuromodulation space. This partnership with CorTec to exclusively manufacture their products to ramp and scale, positions us to bring forth the future of implantable technologies for our customers, driving our vision to improve 100 million lives every year forward."
CorTec’s CEO, Dr. Oliver Baertl, shared the enthusiasm: "Partnering with Heraeus Medevio marks a decisive step in our mission to make the impossible possible for our customers. This cooperation allows Heraeus Medevio and us to combine our strengths. We can now ensure that our customers, regardless of size and location, have access to a complete suite of implantable solutions from prototype to large-scale production, all backed by the highest standards of quality and support."
CTO Dr. Martin Schuettler adds, "This collaboration allows us to extend our engineering expertise across oceans, enhancing our offering with Heraeus Medevio’s large-scale production capabilities. Together, we’re not only bridging continents but also advancing the field of implantable technology as we will be able to deliver next-generation implantable components from the initial start of engineering up to the final series production. Our partnership and the cross-integration of technologies minimizes product development risks for our customers! "
Looking ahead, Medevio is expected to begin high-volume manufacturing of nerve cuff and paddle electrodes based on CorTec’s proprietary laser-micromachining technology by the end of 2025.
Here you can download the press release in english and german language.
About Heraeus
Heraeus is a family-owned global technology group headquartered in Hanau, Germany. The company’s roots go back to a family pharmacy started in 1660. With its expertise and resources, Heraeus has been making meaningful contributions over generations and is committed to do so in the future. Today, the group bundles diverse activities in four Business Platforms: Metals and Recycling, Healthcare, Semiconductor and Electronics, as well as Industrials. Customers benefit from innovative technologies and solutions based on broad materials knowledge and technological leadership. In the 2023 financial year, the group generated revenues of €25.6 billion (US$27.7 billion*) with approximately 16,400 employees in 40 countries. Heraeus is one of the top 10 family-owned companies in Germany.
(* calculated with 2023 average exchange rate, 1€ = 1.0813 US $)
About Heraeus Medevio
Heraeus Medevio, an Operating Company within the healthcare sector of Heraeus Group, is a market-leading medical device design, development, and manufacturing outsourcing partner to medical device OEMs. Heraeus Medevio provides expertise in materials, leading-edge manufacturing technologies, full support throughout the device life cycle, and supply chain excellence to aid customers in the development and production of components, assemblies, and finished devices. With a global production footprint and over 2,500 employees worldwide, Heraeus Medevio is committed to helping its customers bring better medical devices to market.
CorTec was founded in 2010 in Freiburg, Germany. CorTec is offering components and active implantable systems that allow users in industry and clinic to explore new clinical applications and to develop Medical Devices for specific indications. The heart of CorTec’s product portfolio is the Brain Interchange System, which is a fully implantable investigational wireless device for both sensing and stimulating on 32 channels. The system is designed for discovery of novel therapies for the central nervous system and for the exploration of neuromodulation as well as brain-computer interface applications.
CorTec GmbH
Neuer Messplatz 3
79108 Freiburg
Telefon: +49 (761) 70888100
Telefax: +49 (761) 70888399
https://cortec-neuro.com/
E-Mail: pr@cortec-neuro.com
Head of Marketing
Telefon: +49 (0)761 70888200
E-Mail: pr@cortec-neuro.com
CTO
Telefon: +49 (761) 70888-100
Fax: +49 (761) 70888-399
E-Mail: info@cortec-neuro.com
CEO
Telefon: +4976170888100
Fax: +4976170888399
E-Mail: info@cortec-neuro.com

